CD79A and Thrombocytopenia: Finally, while our findings are suggestive of a pathological role for IgA in PUUV-HFRS, further studies are needed to elucidate the precise mechanisms through which IgA contributes to the development of AKI, thrombocytopenia and vascular permeability.